Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenqi Fuzheng Injection for Cancer-related Fatigue in Gastrointestinal Cancer
NCT03456609Unknown
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Start
- Jan 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of shenqi fuzheng injection in cancer-related fatigue (CRF) (2 arms), sponsored by Livzon Pharmaceutical Group Inc. Primary endpoint: Piper Fatigue Scale at 42 days. Status: unknown.
02
Drugs
shenqi fuzheng injection
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT03456609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03456609.